AELIS FARMA’s Post

The Summit on Breakthrough Therapies for Addiction Organized by: @momentumpbc **Wednesday, May 15, 2024 9:00 am to Thursday, May 16, 2024 6:00 pm** Register!!! (https://lnkd.in/ga4-Hh5Y) This pioneering conference aims to showcase the transformative potential of cutting-edge research and treatment protocols. It includes psychedelics, non-hallucinogenic compounds, neuromodulation, digital therapeutics, virtual reality, patient care, and novel integration models, all designed to expedite addiction treatment. The event will feature the latest research, delving into how these groundbreaking therapies facilitate trauma healing, promote neuroplasticity, and foster personal growth for individuals dealing with addiction. Bringing together scientists, clinicians, medical experts, policy advocates, and individuals with firsthand experience overcoming addiction through these treatments, the conference serves as a nexus for inspiring hope in advancing evidence-based approaches to innovative substance use disorder treatments. Join us to explore the promising future of aiding individuals in reclaiming their lives. #mentalhealth #veterans #miami

Addiction Medicine Grand Rounds: SAMHSA’s Final Rule on Methadone: Implications for Implementation, Patient Outcomes, and Future Directions March 26, 2024 — 12PM to 1:30PM ET 📍 REGISTRATION: https://lnkd.in/g4kV9_Nv The Yale Program in Addiction Medicine is pleased to welcome hold a special session of Addiction Medicine Grand Rounds on March 26th, 2024, 12:00-1:30pm, with invited panelists detailed below. This event will be held virtually via Zoom and extend a half hour longer than our typical sessions. Topic: SAMHSA’s Final Rule on Methadone: Implications for Implementation, Patient Outcomes, and Future Directions Learning objectives: ☑️ Describe key regulatory changes introduced by SAMHSA’s Final Rule on Methadone. ☑️ Consider mechanisms of enforcement, monitoring, and evaluation during implementation of regulatory changes in methadone treatment settings. ☑️ Discuss implications of changes in methadone regulation for treatment facilities, healthcare providers, and patients receiving methadone. Addiction Medicine Grand Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM. #Methadone #ProfessionalDevelopment

Excited to share our latest publication! Our study delved into the experiences of individuals in recovery from substance use issues in Flanders, Belgium. They shared valuable insights into their usage patterns, treatment journeys, and life circumstances during addiction. We compared those who underwent treatment with those who recovered without professional or peer assistance. Our findings show that unassisted recovery isn't solely tied to the severity of the issue. It's also influenced by i.e. health, legal, and financial life circumstances during addiction. https://lnkd.in/edx-_d_2

Meet Dr. Kathryn A. Cunningham, Director of the UTMB Health Center for Addiction Sciences and Therapeutics at The University of Texas Medical Branch. Substance use disorders (SUDs) pose a significant challenge, as they often damage brain function related to motivation and decision-making. While psychedelics like psilocybin have shown promise in helping with recovery, their risks—such as hallucinations and safety concerns—make them challenging to use widely. Dr. Cunningham is working on a solution that focuses on developing new compounds that similarly boost brain function but without harmful side effects. This approach could open up new, safer treatment options for those struggling with cocaine and stimulant addiction, areas where no approved medications currently exist. Welcome to #I4SUD2024, Dr. Cunningham! #AddictionRecovery #MentalHealthInnovation #SubstanceUseDisorder #HealthcareSolutions #SUDTreatment

#resource alert. The debate over whether addiction is a disease or a choice continues to evolve. An article in The New York Times explores how experts now believe addiction involves both elements: while the brain's biology plays a significant role, personal choices also factor into substance abuse and recovery. This dual understanding helps to address the complexity of addiction, leading to more effective treatment approaches. The discussion highlights the need for compassion, support, and tailored care for those struggling with addiction. Read more here: https://lnkd.in/eFbmm3yT

One week left to register for The Summit on Breakthrough Therapies for Addiction! Here's why you should attend: 1. **Cutting-Edge Insights**: Explore the latest in Ibogaine, Ketamine, DMT, and more for transformative treatment. 2. **Diverse Perspectives**: Gain insights on treating different demographics and modalities like digital therapeutics and neuromodulation. 3. **Real-World Evidence**: Analyze outcomes from OSU’s Ibogaine Treatment Registry, shaping addiction recovery. 4. **Practical Integration Models**: Learn to seamlessly integrate therapies into existing frameworks for lasting recovery. 5. **Visionary Exploration**: Join thought leaders discussing the future of addiction treatment. Don't miss this transformative event! Learn more and register in person or live stream. https://lnkd.in/giRJsyFk. See you there!   #AddictionTreatment #BreakthroughTherapies #Conference #HealthcareInnovation

The June issue of TPharm is now live! Read about psychiatrist Marie Nyswander, her work to find successful treatment options for addiction and her collaborations that led to a pharmacological breakthrough for addiction. Read the issue here: https://bit.ly/4cETDe9 #pharmacology

⭐ ORI Scientist featured in Addiction Technology Transfer Center Network’s July issue of the ATTC Messenger ⭐ ORI research scientist Camille Cioffi, Ph.D., and her colleagues address how researchers with lived (and living) experience (RLE) with substance use disorders can help translate research into practice and contribute to the successful implementation of evidence-based interventions. The post, entitled “Researchers with Lived Experience: Closing the Research-To-Practice Gap in Substance Use Systems of Care,” outlines how RLE may be purposefully included to help improve responsiveness to community needs, reduce stigma, and improve outcomes. To learn more, read the post here: https://lnkd.in/gAdpiajz

Brand New Post regarding ASAM Standards! You won't want to miss this! Since the 1990’s, the American Society of Addiction Medicine (ASAM) has set the standards for the treatment of addictions in the United States. Private insurance, state behavioral health authorities and federal programs use the ASAM Criteria to design, implement and evaluate assessment and treatment of substance use disorders. For the first time, an entire chapter is devoted to this topic and, more important, introduces the concept of “Neurologic Informed Care”. Paralleling “Trauma Informed Care”, the ASAM Criteria set the expectation that treatment providers will identify and accommodate cognitive impairments in all the programs they provide. The primary expectation is that programs train staff to understand cognitive impairment (neurologic-informed care), be able to recognize it in the persons they provide care to (neurologic-responsive care), and have the skills for providing simple accommodations to minimize the effect on treatment (neurologic-specific care). Dr. Corrigan was a co-author of the Cognitive Impairment chapter and championed the Neurologic Informed Care approach. To read more.. https://lnkd.in/eaXdPsAd

I’m honored to be listed as a diagnostic provider to evaluate for Fetal Alcohol Spectrum Disorder with NC FASD. Over 90% of people with this disorder suffer without the resources they need due to a lack of providers who are comfortable and confident in making this diagnosis. This diagnosis is made through a comprehensive evaluation and review of the patient's history and services that help those with this condition can be difficult to access without strong advocacy. ICGH has long been a strong advocate for people with substance use disorder. Studies show that many of those with active substance use disorder challenges actually have undiagnosed FASD. By helping patients get the services they need at a young age, we hope to break the cycle of addiction and help children achieve to their full potential. There is no shame or blame. We are only focused now on early identification and proper services to tame! If you, or someone you know, has a child or adolescent who may have a history of in-utero substance exposure and they are struggling emotionally, academically, or with neurodivergency, contact our office for an evaluation. Referral links can be found at www.GrowingMinds.clinic For more information and resources about FASD, click this link. https://lnkd.in/g3Qqqsqx